| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. (TARS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. TARS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $56.05M | - | |
| Dir | 108.7K | $7.10M | - | |
| COO | 79.2K | $5.17M | - | |
| Other | 56.8K | $3.71M | - | |
| Other | 24.3K | $1.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 6,000 | $50.00 | $300,000.00 | -0.7% | +45.4% | - | |
| Jun 17, 2025 | Farrow Jeffrey S | See Remarks | Sale+OE | 13,608 | $40.42 | $550,035.36 | -27.0% | +25.8% | +57.2% | |
| Jun 16, 2025 | Lin Elizabeth Yeu | Chief Medical Officer | Sale+OE | 1,006 | $41.08 | $41,326.48 | -11.6% | +20.1% | +50.0% | |
| Jun 9, 2025 | Mottiwala Aziz51 | Chief Commercial Officer | Sell | 17,500 | $43.76 | $765,800.00 | -26.9% | +32.0% | - | |
| Mar 24, 2025 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 6,000 | $50.00 | $300,000.00 | -0.7% | -22.5% | +20.6% | |
| Mar 20, 2025 | Mottiwala Aziz51 | Chief Commercial Officer | Sell | 10,565 | $47.88 | $505,856.42 | -4.9% | -17.7% | +29.3% | |
| Mar 20, 2025 | Neervannan Seshadri | Chief Operating Officer | Sell | 7,583 | $47.89 | $363,141.50 | -3.0% | -17.7% | +29.3% | |
| Mar 20, 2025 | Wahl Bryan | General Counsel | Sell | 9,686 | $47.88 | $463,765.53 | -5.6% | -17.7% | +29.3% | |
| Mar 20, 2025 | Farrow Jeffrey S | See Remarks | Sell | 3,724 | $47.88 | $178,306.42 | -5.0% | -17.7% | +29.3% | |
| Mar 20, 2025 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 24,216 | $48.03 | $1,163,050.13 | -11.5% | -17.7% | +29.3% |